Morgan Stanley upgraded XP Inc. (XP) to Overweight from Equal Weight with a price target of $24, up from $18 as part of a broader research note on Brazil Financial Institutions. The stock offers leveraged exposure to rising equity trading volumes and capital markets recovery, the analyst tells investors in a research note. XP also stands to benefit from two key effects of falling rates – portfolio rotation and renewed investor confidence, the firm added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XP: